Holen Sie sich die Stockscreener-App
1.51
28.77%
-0.61
Handel nachbörslich:
1.55
0.04
+2.65%
Schlusskurs vom Vortag:
$2.12
Offen:
$1.56
24-Stunden-Volumen:
807.26K
Relative Volume:
17.93
Marktkapitalisierung:
$5.51M
Einnahmen:
$3,000
Nettoeinkommen (Verlust:
$-5.16M
KGV:
-1.0684
EPS:
-1.4133
Netto-Cashflow:
$-5.43M
1W Leistung:
-29.77%
1M Leistung:
-48.11%
6M Leistung:
-65.91%
1J Leistung:
-77.56%
1-Tages-Spanne:
$1.41
$1.66
1-Wochen-Bereich:
$1.41
$2.49
52-Wochen-Spanne:
$1.41
$9.37
Pulmatrix Inc Stock (PULM) Company Profile
Firmenname
Pulmatrix Inc
Sektor
Branche
Telefon
(888) 355-4440
Adresse
945 CONCORD STREET, FRAMINGHAM, MA
Compare PULM vs VRTX, REGN, ALNY, ARGX, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PULM
Pulmatrix Inc
|
1.51 | 7.74M | 3,000 | -5.16M | -5.43M | -1.4133 |
VRTX
Vertex Pharmaceuticals Inc
|
453.74 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
756.73 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.16 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
692.83 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
147.60 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Pulmatrix Inc Stock (PULM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2018-02-09 | Eingeleitet | H.C. Wainwright | Buy |
Pulmatrix Inc Aktie (PULM) Neueste Nachrichten
Pulmatrix and Eos SENOLYTIX Unite to Pioneer Anti-Aging Therapies Targeting Mitochondrial Health - Beijing Times
Deal Watch: Pulmatrix Finds New Merger Partner In Eos Senolytix - Citeline News & Insights
Eos SENOLYTIX, Inc. agreed to acquire Pulmatrix, Inc. in a reverse merger transaction. - marketscreener.com
Pulmatrix: Merger With Eos SENOLYTIX To Advance Mitochondrial Therapies - Pulse 2.0
Pulmatrix To Merge with Eos SENOLYTIX - citybiz
If You Invested $1,000 in Pulmatrix (PULM) - Stock Titan
Pulmatrix (PULM) to Acquire Eos Senolytix in Strategic Merger - GuruFocus
Pulmatrix to acquire Eos SENOLYTIX in $19M anti-aging deal - Investing.com
Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan - PR Newswire
Pulmatrix shares dive as privately-held pharma company chooses to merge with Gyre Therapeutics instead - MSN
Buyout Rumor: Can Pulmatrix Inc grow without dilution2026 Closing Moves & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Pulmatrix (NASDAQ:PULM) Stock Crosses Above Fifty Day Moving Average – Here’s Why - Defense World
Aug Catalysts: What are the analyst revisions for Vroom IncIs Pulmatrix Inc stock a good investment in YEARTrade Exit Report & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Risk Off: What is the earnings history of Pulmatrix IncWeekly Stock Report & Weekly High Conviction Ideas - baoquankhu1.vn
Why Pulmatrix Inc. stock is a value investor pickJuly 2025 Price Swings & Daily Growth Stock Investment Tips - Naître et grandir
Surprises Report: Will Pulmatrix Inc benefit from rising consumer demandShare Buyback & Capital Efficient Trade Techniques - baoquankhu1.vn
Pulmatrix, Inc. (PULM) Competitors - Meyka
PULM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Pulmatrix Pursues New Reverse Merger After Cullgen Termination - The Globe and Mail
Pulmatrix merger with Cullgen terminated by Chinese firm - Investing.com
Behavioral Patterns of PULM and Institutional Flows - Stock Traders Daily
Pulmatrix Shares Dive As Privately-Held Pharma Company Chooses To Merge With Gyre Therapeutics Instead - Asianet Newsable
Pulmatrix and Cullgen Terminate Merger Agreement - Contract Pharma
Pulmatrix (PULM) Pursues New Merger Opportunities Post Agreement Termination - GuruFocus
Pulmatrix announces termination of prior planned merger and continues pursuit of alternative merger opportunities - marketscreener.com
Pulmatrix Announces Termination Of Prior Planned Merger And Continues Pursuit Of Alternative Merger Opportunities - TradingView
Pulmatrix-Cullgen Merger Agreement Terminated; No Fees Payable - TradingView
CSRC delays leave Pulmatrix merger dead, company hunts new deal - Stock Titan
Pulmatrix, Inc. SEC 10-K Report - TradingView
Pulmatrix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
PULM: Revenue fell to nil in 2025 as the company pivots to merger and asset monetization strategies - TradingView
Pulmatrix (NASDAQ: PULM) cuts 2025 loss to $5.2M as Cullgen merger awaits approvals - Stock Titan
Pulmatrix Announces Year-End and Fourth Quarter 2025 Financial Results - PR Newswire
Pulmatrix Announces Year-End and Fourth Quarter 2025 Financial Results | PULM Stock News - Longbridge
PULM PE Ratio & Valuation, Is PULM Overvalued - Intellectia AI
Why Pulmatrix Inc. stock is in analyst buy zone2025 Market Trends & Low Risk Entry Point Guides - mfd.ru
Update Report: Will Pulmatrix Inc benefit from seasonalityVolume Spike & Technical Buy Zone Confirmations - baoquankhu1.vn
(PULM) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Earnings Report: What is the earnings history of Pulmatrix IncPortfolio Value Summary & AI Driven Price Forecasts - baoquankhu1.vn
Pulmatrix (NASDAQ:PULM) Share Price Crosses Below 50 Day Moving Average – What’s Next? - Defense World
Will Pulmatrix Inc. stock gain from strong economy2025 Macro Impact & Safe Swing Trade Setup Alerts - mfd.ru
Is Pulmatrix Inc. stock a buy before product launchesPortfolio Profit Report & AI Driven Stock Movement Reports - mfd.ru
Pulmatrix Announces Third Quarter 2024 Financial Results and Pro - GuruFocus
Is Pulmatrix Inc. stock a defensive play in 2025Short Setup & Technical Pattern Alert System - mfd.ru
Can Pulmatrix Inc. deliver alphaJuly 2025 Volume & Weekly Return Optimization Plans - mfd.ru
Will Pulmatrix Inc. benefit from rising consumer demandJuly 2025 Reactions & Free Risk Controlled Daily Trade Plans - mfd.ru
How (PULM) Movements Inform Risk Allocation Models - Stock Traders Daily
Profit Review: Will Pulmatrix Inc benefit from rising consumer demandPortfolio Value Report & Low Risk Entry Point Guides - baoquankhu1.vn
Will Pulmatrix Inc benefit from rising consumer demandPortfolio Value Report & Low Risk Entry Point Guides - baoquankhu1.vn
Market Review: Will Pulmatrix Inc benefit from rising consumer demandPortfolio Performance Report & Weekly Return Optimization Plans - baoquankhu1.vn
Aug Intraday: Will Greif Inc stock benefit from M AMarket Trend Report & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Finanzdaten der Pulmatrix Inc-Aktie (PULM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.04%
0.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):